CDMOHUBCDMOHUB
Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    1. Home
    2. /CDMOs
    3. /Oxford Biomedica (OXB)
    Oxford Biomedica (OXB) logo

    Oxford Biomedica (OXB)

    CDMO
    United Kingdom
    https://oxb.com/

    Is this your company? Claim this profile

    Advanced Modalities
    Regulatory, Tech Transfer & Support Services
    Analytical & Bioanalytical Services
    Drug Product
    Chemistry, Manufacturing and Controls
    Company Overview

    About

    Oxford Biomedica (OXB) is a global, quality- and innovation-led CDMO specializing in viral vector development and manufacturing for cell and gene therapy. With 25+ years of experience, OXB is the first and currently only FDA-approved CDMO for commercial production of lentiviral vectors for CAR-T therapy. The company operates GMP suites across three countries with extensive end-to-end capabilities in lentivirus, AAV, and adenovirus vectors.

    Key Expertise

    Viral vector CDMO with proprietary LentiVector and inAAVate platforms. End-to-end capabilities from plasmid design and optimization through clinical and commercial GMP manufacturing. First commercial supplier of lentiviral vectors for a CAR-T therapy. Strong regulatory track record with 150+ successful audits.

    Therapeutic Areas

    Oncology
    Rare Diseases
    Ophthalmology
    CNS (Central Nervous System)
    Quick Facts
    HQ:United Kingdom
    Capabilities & Services

    Core Capabilities

    • Viral Vectors
    • Cell & Gene Therapy
    • Gene Therapy

    Containment Capabilities

    BSL-2 (Biosafety Level 2)

    Production Scales

    R&D / Pre-clinical
    Clinical
    Commercial Scale

    Markets Served

    Europe
    North America
    Manufacturing Facilities

    3 sites worldwide

    Oxford Biomedica (OXB) - France Facility

    France
    View on Map

    Oxford Biomedica (OXB) - United Kingdom Facility

    United Kingdom
    View on Map

    Site Capabilities

    3 capabilities
    API Manufacturing
    Sterile Fill/Finish
    Lyophilization

    Oxford Biomedica (OXB) - United States Facility

    United States
    View on Map

    Site Capabilities

    3 capabilities
    API Manufacturing
    Sterile Fill/Finish
    Lyophilization
    Clinical Trial Experience

    Involvement in 2 clinical trials

    Therapeutic Areas
    CNS/Neurology
    Oncology
    Certifications

    FDA Registration

    U.S. Food and Drug Administration

    EMA GMP Certificate

    European Medicines Agency

    MHRA GMP

    UK Medicines and Healthcare products Regulatory Agency
    Request an Introduction

    Please log in to contact this provider.

    Key facts about Oxford Biomedica (OXB)

    • Oxford Biomedica (OXB) is headquartered in the United Kingdom.
    • Oxford Biomedica (OXB) has 3 manufacturing sites listed on CDMO Hub, in France, the United Kingdom and the United States.
    • Oxford Biomedica (OXB)'s capabilities include Viral Vectors, Cell & Gene Therapy and Gene Therapy.

    Find CDMOs like Oxford Biomedica (OXB)

    Directory pages this company appears in, each with the full list of matching manufacturers.

    CDMOs in United KingdomCDMOs in EuropeViral Vectors CDMOsCell & Gene Therapy CDMOsBSL-2 (Biosafety Level 2) CDMOs
    CDMOHUB

    Connecting biotech and pharma teams with contract manufacturing partners worldwide.

    Platform

    • Find CDMOs
    • CDMO Matchmaking
    • Expert Matchmaking
    • SmartRFI
      Members
    • Modality Guides
    • Supplier Maps
    • Join as Partner

    Company

    • Blog
    • Briefings
    • About Us
    • Contact

    Legal

    • Terms of Service
    • Privacy Policy

    © 2026 CDMOHUB. All rights reserved.

    CDMO Hub, Inc. Registered in Delaware, USA